Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

The How: Evidence-Based Testing Strategies to Detect Appropriate Gene Alterations (39 mins)

Gain insights from Laura J. Tafe, MD, a molecular pathologist, on best practices for biomarker testing in lung cancer.
Nathan Pennell, MD, PhD
Laura J. Tafe, MD
Released: January 15, 2021 Expiration: No longer available for credit

This program is divided into several short segments that you can step through using the Video Chapters menu.

Related Content

Experts answer pressing audience questions from a live satellite symposium on the management of relapsed/refractory multiple myeloma, from Clinical Care Options (CCO)

Paul G. Richardson, MD
Program Director
Natalie S. Callander, MD Noopur Raje, MD
Released: August 18, 2022

Safety and response data from phase Ib TROPION-Lung02 study of Dato-DXd plus pembrolizumab with or without platinum chemotherapy in advanced NSCLC, presented at WCLC 2022 reported by Clinical Care Options (CCO)

Released: August 18, 2022

Results from the HUDSON umbrella trial of novel durvalumab combination regimens in patients with advanced NSCLC who failed previous immunotherapy treatment, presented at WCLC 2022 and reported by Clinical Care Options (CCO)

Released: August 18, 2022

Initial PFS and OS results from phase II NADIM II study of neoadjuvant nivolumab plus CT vs CT alone in patients with resectable stage IIIA-B NSCLC, presented at WCLC 2022 and reported by Clinical Care Options (CCO)

Released: August 18, 2022

Video Chapters


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Lilly

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings